{rfName}
ON

Información del proyecto

ID: MSCA-ITN-ETN 2014

Fecha inicio

01-01-2015

Fecha fin

31-05-2019


Coordinador institucional
Universidad Autónoma de Madrid

Financiación

3 893 983,37 Euros
(Total amount or amount awarded)

Más información en

Análisis de autorías institucional

Mayor Menendez, FedericoInvestigador principalPenela Marquez, PetronilaInvestigador/a
Compartir
Proyectos I+D+I y Ayudas
>
Proyecto Competitivo

ONCOgenic Receptor Network of Excellence and Training

Investigadores/as: Penela Marquez, Petronila (Investigador/a); Mayor Menendez, Federico (Investigador principal (IP))

Afiliaciones

UAM. Facultad de Ciencias. Biología Molecular (University Department)
UAM. Programa de Doctorado en Biociencias Moleculares (Doctorate Program)
UAM. REDES DE SEÑALIZACIÓN CELULAR EN CÁNCER (Group)
UAM. Redes De Señalizacion Celular Del Cáncer (Group)
UAM. Implicaciones Fisiopatológicas De La Señalización Celular Por Grks Y Gpcrs (Group)
UAM. Instituto Universitario de Biología Molecular (R & D Center)
UAM. Facultad de Ciencias. Biología Molecular (University Department)
Ver más

Resumen

Draft Periodic Report (Most relevant results); Draft Periodic Report (Summary)
Palabras clave
Dna virusesDrug discoveryEntrepreneurshipOncologyProteomics

Instituciones participantes

Indicios de calidad

Programa

EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions; Marie Skłodowska-Curie Innovative Training Networks (ITN-ETN); Fostering new skills by means of excellent initial training of researchers

Agencias financiadoras

H2020

Alcance

Unión Europea

Coordinador institucional

Si

Ítems relacionados

Tipo de relaciónReferenciaCode/ID ExternoEnlace
Producto deMolecular Pharmacology of Chemokine Receptors10.1016/bs.mie.2015.12.002
Producto deAtypical chemokine receptor 3 (ACKR3): a comprehensive overview of its expression and potential roles in the immune system.10.1124/mol.118.115329
Producto deTime-Resolved FRET-Based Assays to Characterize G Protein-Coupled Receptor Hetero-oligomer Pharmacology10.1007/978-1-4939-9121-1_8
Producto deNanobodies: New avenues for imaging, stabilizing and modulating GPCRs10.1016/j.mce.2019.01.021
Producto deCXCR4/ACKR3 phosphorylation and recruitment of interacting proteins: key mechanisms regulating their functional status10.1124/mol.118.115360Ver en iMarina
Producto deThe role of ACKR3 in breast, lung and brain cancer.10.1124/mol.118.115279Ver en iMarina
Producto deStructure-based exploration and pharmacological evaluation of N-substituted piperidin-4-yl-methanamine CXCR4 chemokine receptor antagonists10.1016/j.ejmech.2018.10.060
Producto deCXCR4-targeting nanobodies differentially inhibit CXCR4 function and HIV entry10.1016/j.bcp.2018.10.015
Producto deG protein-coupled receptor kinases (GRKs) in tumorigenesis and cancer progression: GPCR regulators and signaling hubs10.1016/j.semcancer.2017.04.013Ver en iMarina
Producto deNanobody-Fc constructs targeting chemokine receptor CXCR4 potently inhibit signaling and CXCR4-mediated HIV-entry and induce antibody effector functions10.1016/j.bcp.2018.10.014
Producto deFluorescent-Based Strategies to Investigate G Protein-Coupled Receptors: Evolution of the Techniques to a Better Understanding10.1007/7355_2017_2
Producto deG-Protein–Coupled Receptor Kinase 2 as a Potential Modulator of the Hallmarks of Cancer10.1124/mol.116.107185Ver en iMarina
Producto deDNA immunization combined with scFv phage display identifies antagonistic GCGR specific antibodies and reveals new epitopes on the small extracellular loops10.1080/19420862.2016.1189050
Producto deCXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome10.1124/jpet.117.242735
Producto deG Protein-coupled Receptor Kinase 2 (GRK2) Promotes Breast Tumorigenesis Through a HDAC6-Pin1 Axis10.1016/j.ebiom.2016.09.030Ver en iMarina
Producto dePeripheral Interaction of Resolvin D1 and E1 with Opioid Receptor Antagonists for Antinociception in Inflammatory Pain in Rats10.3389/fnmol.2017.00242
Producto deNatural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement10.1038/ncomms14253
Producto deStructural Analysis of Chemokine Receptor–Ligand Interactions10.1021/acs.jmedchem.6b01309
Producto deDraft Periodic Report
Producto deONCORNET website
Producto deOpen meetings organized
Producto deMid-Term Review meeting
Producto deProgress Report
Producto deEthics
Producto dePeriodic Reporting for period 2 - ONCORNET (ONCOgenic Receptor Network of Excellence and Training)
Producto deOutput
Producto deSupervisory board of Network